Stay updated on Pembrolizumab Combo in Resectable NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.6.3 was added and Revision: v3.6.2 was removed. This indicates the page's revision history has been updated.
    Difference
    0.0%
    Check dated 2026-07-03T22:30:01.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision label changed from v3.6.0 to v3.6.2, indicating a patch-level update to the page. This update does not alter study content or results.
    Difference
    0.0%
    Check dated 2026-06-26T19:59:24.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A recruitment-status indicator was added, signaling that the study is no longer recruiting participants. Additionally, new navigation/help items were added, the Interventions header formatting was standardized to Intervention/Treatment, and the revision tag was updated from v3.5.5 to v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-12T13:30:09.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.5.5 was added, replacing Revision: v3.5.4 on the page metadata.
    Difference
    0.0%
    Check dated 2026-06-05T08:47:00.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.5.4 and the previous v3.5.3 tag was removed, signaling a small update to the page’s revision history.
    Difference
    0.0%
    Check dated 2026-05-14T23:19:03.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Taoyuan District, Taiwan, 333 was removed and Taoyuan, Taiwan, 333 was added to the study locations in Taiwan. This updates the geographic coverage and enrollment options for participants in that region.
    Difference
    0.0%
    Check dated 2026-05-07T21:50:34.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Resectable NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page.